EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER

Our surveillance was performed for 358 patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH. Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 136) received treatment with 75 mg Buserelin-depo 3....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: S. V. MISHUGIN, A. A. DROBYAZKO, A. A. MORDOVIN, A. A. GRICKEVICH, I. G. RUSAKOV
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: Remedium Group LLC 2017-06-01
Cyfres:Медицинский совет
Pynciau:
prostate cancer
hormone therapy
agonists of luteinizing hormone releasing hormone
buserelin
prostate-specific antigen
testosterone
Mynediad Ar-lein:https://www.med-sovet.pro/jour/article/view/1893
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg